FDA Workshop Focuses on Pediatric Hypertension Treatments (DAY 2)

The U.S. Food and Drug Administration continues its public workshop at 9 a.m. ET on July 16 on the development of antihypertensive therapies for pediatric patients. The second day focuses on advancing ...